Evidence supporting the use of: Silydianin
For the health condition: Hepatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Silydianin is one of the flavonolignans found in the extract of Silybum marianum (milk thistle), which is traditionally used for liver disorders, including hepatitis. Most of the research and clinical use focuses on the broader extract, silymarin, which is composed of several related compounds, including silydianin, silybin, and silychristin. There is some scientific evidence supporting the hepatoprotective effects of silymarin in hepatitis, attributed to its antioxidant, anti-inflammatory, and antifibrotic properties. However, clinical trials specifically isolating silydianin are very limited. Most available data are from studies on silymarin as a whole or on silybin, its major component.

Animal and in vitro studies suggest that silydianin may contribute to the inhibition of hepatic stellate cell activation and may reduce oxidative stress in liver tissue. Some small human trials and meta-analyses on silymarin suggest modest benefit in improving liver enzyme levels and possibly reducing symptoms in chronic hepatitis, but the evidence is inconsistent and often of low quality. There is no strong clinical evidence isolating silydianin’s effect in hepatitis, and thus its specific therapeutic value remains uncertain. Overall, while the use of silymarin (and by extension, silydianin) in hepatitis has some scientific rationale and preliminary evidence, it is not robustly validated by large, high-quality clinical trials, and its use should be considered with caution.

More about Silydianin
More about Hepatitis

Products containing Silydianin

We currently have no products on Vitabase that contain this ingredient.